Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure in Participants With Atherosclerotic Cardiovascular Disease or Risk Equivalents and Elevated Low-Density Lipoprotein Cholesterol

NCT06692764 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06692764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06692764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure in Participants With Atherosclerotic Cardiovascular Disease or Risk Equivalents and Elevated Low-Density Lipoprotein Cholesterol
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2024
Completion date
May 2, 2025
Enrollment
202 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease